-
NEWS
New Data Reveals BD's Artificial Intelligence Software Highly Effective in Detecting Indicators of Controlled Substance DiversionLearn MoreBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new data that highlights how its advanced artificial intelligence technology can help...
-
NEWS
BD Expands Capacity for Advanced Prefillable Syringes and Enhances Injection Experience for the Next Generation of BiologicsLearn MoreBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe and the...
-
BLOG
Together We AdvanceWe are proud to share a report of impact and progress made toward the goals and commitments we set for 2030+ to advance the health of our company, planet, communities and people.Learn More